RIBOMIC announces positive top-line results from phase 1/2a trial of rbm-007 in wet AMD

Image: RIBOMIC announces positive top-line results from phase 1/2a trial of rbm-007 in wet AMD. Photo: courtesy of PublicDomainPictures/Pixabay.